Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

News Briefs: FDA Program Alignment Group; CardioMEMS Panel; HCV Coverage Analysis

This article was originally published in The Gray Sheet

Executive Summary

FDA announces the formation of a new Program Alignment Group, made up of center directors and other officials, and schedules an workshop on intraocular lenses. The agency’s Circulatory System Devices panel will review CardioMEMS’ pulmonary monitoring system again and Medtronic devices. CMS opens coverage analysis for hepatitis C screening. More news.

You may also be interested in...



Medtronic Takes Aim At Implantable Device Infections With TYRX Buy

The $160 million cash acquisition fits with the firm’s efforts to fashion itself into a health care services and solutions company, rather than a pure device firm. TYRX makes anti-bacterial envelopes for implanted devices, and has FDA clearances for use of its products with cardiac implantable electronic devices and spinal cord neurostimulators.

Medtronic Takes Aim At Implantable Device Infections with TYRX Buy

The $160 million cash acquisition fits with the firm’s efforts to fashion itself into a health care services and solutions company, rather than pure device firm. TYRX makes anti-bacterial envelopes for implanted devices, and has FDA clearances with cardiac implantable electronic devices and spinal cord neurostimulators.

Reimbursement Briefs: National Coverage Updates; MolDx Meeting Request; Sleep Study Questions

Hepatitis C virus screening national coverage supported in comments. Proposed decision memo delayed for percutaneous image-guided lumbar decompression for lumbar spinal stenosis national coverage determination. More reimbursement news.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT032382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel